Početna › Difuzni veliki B-stanični limfom › North Carolina › Durham
Kliničke studije za Difuzni veliki B-stanični limfom u gradu Durham, NC
14 studija za Difuzni veliki B-stanični limfom traži sudionike na lokacijama u gradu Durham i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
U tijeku regrutacijaFaza 2
- Duke Blood Cancer Center, Durham
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
U tijeku regrutacijaFaza 3
- Duke University Medical Center, Durham
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
U tijeku regrutacijaFaza 2
- University of North Carolina Medical Center ( Site 0136), Chapel Hill · 10 mi udaljenosti
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
U tijeku regrutacijaFaza 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 mi udaljenosti
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
U tijeku regrutacijaOpažajna studija
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
U tijeku regrutacijaFaza 3
- Duke Cancer Institute, Durham
DALY II USA/ MB-CART2019.1 for DLBCL
U tijeku regrutacijaFaza 2
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
U tijeku regrutacijaFaza 1
- Duke University Medical Center, Durham
Registry of Older Patients With Cancer
U tijeku regrutacijaOpažajna studija
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi udaljenosti
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
U tijeku regrutacijaFaza 1
- Duke Univerisity, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
U tijeku regrutacijaOpažajna studija
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi udaljenosti
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
U tijeku regrutacijaFaza 1
- University of North Carolina, Chapel Hill · 10 mi udaljenosti
A Study of NX-1607 in Adults With Advanced Malignancies
U tijeku regrutacijaFaza 1
- University of North Carolina, Chapel Hill · 10 mi udaljenosti
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
U tijeku regrutacijaFaza 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi udaljenosti
Studije za Difuzni veliki B-stanični limfom u drugim gradovima
- New York City, NY21 studija
- Baldwin Park, CA19 studija
- Chicago, IL18 studija
- Houston, TX17 studija
- Los Angeles, CA17 studija
- Boston, MA16 studija
- Milwaukee, WI16 studija
- Nashville, TN15 studija
- Portland, OR15 studija
- Philadelphia, PA15 studija
- Dallas, TX13 studija
- Seattle, WA12 studija
Ostale studije u gradu Durham
- Rak dojke63 studija
- Rak (sve vrste)58 studija
- Nemikrocelularni karcinom pluća39 studija
- Multipli mijelom37 studija
- Metastatski karcinom33 studija
- Akutna mijeloična leukemija33 studija
- Rak pluća32 studija
- Rak prostate32 studija
- Kolorektalni rak28 studija
- Kronična limfocitna leukemija27 studija
- Rak jajnika27 studija
- Srčano zatajenje26 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.